SACRAMENTO, Calif., May 19, 2016 -- The Orange County Register published an opinion piece today by Bridget Hood, a lupus survivor and Lupus L.A. board member and support group facilitator. May is Lupus Awareness Month, dedicated to raising awareness and promoting medical innovation to find treatments or a cure for this debilitating autoimmune disease. Hood has been a continued voice for medical innovation and research.
In the opinion piece, "A time to recommit to the fight against lupus," Hood makes the case that policy makers must do everything in their power to create policies that protect patients and ensure these life-saving medications are available to all who need them.
"The right kinds of public policy can offer hope for those of us who are fighting for new treatments and a cure. Policy makers in Sacramento and Washington D.C. play an important role in helping patients continue their fight. It is vital that we continue to move forward with medical innovation, and not make any kind of policy decisions that would intentionally or unintentionally slow that progress down."
View the full column at The Orange County Register: http://www.ocregister.com/articles/lupus-716357-patients-disease.html
Learn more about the value of medical innovation at www.CALifeSciences.org/Innovation.
|
|||||
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. CLSA works closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Media Contact:
Will Zasadny
Associate Director, Communications
[email protected]
CONTACT: Will Zasadny
Associate Director, Communications
[email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



